The oral route of drug administration is the most important and most user-friendly route of administration. In recent years, Multiple Unit Pellet Systems (MUPS) tablets are widely used in solid dosage form design. MUPS is considered to provide pharmacokinetic advantages compared to monolithic dosage forms. Typically, modified release pellets are contained in MUPS tablets. Modified release drug delivery systems have acquired very important role in pharmaceutical research and development. 1. The compression of multiparticulates into tablets, unlike the hard gelatin capsule, is a tamper-proof dosage form and has greater physicochemical and microbiological stability of pellets as they are embedment in the inert matrix.
2. Tablets have less difficulty in esophageal transport than capsules.
3. Tablets containing coated subunits can be prepared at a lower cost than these subunits filled into hard gelatin capsules because of higher production rate of the tablet press. 4. The expensive control of capsule integrity after filling is also eliminated.
5. In addition, tablets containing multiparticulates without losing the controlled-release properties could be scored, which allow a more flexible dosage regimen.
Pelletization techniques:
The preparation of spherical agglomerates can be approached by several techniques which can be subdivided into the basic types of systems shown in figure 3. 
OBJECTIVES OF WORK
Formulation and evaluation of aspirin release from matrix pellets compressed into MUPS tablet.
Present study was carried out with following objectives:
• To develop a stable formulation of Aspirin MUPS Pellets with optimization of polymer, in different concentration, for matrix former on pellets.
• To develop a tablet formulation for Aspirin Pellets with optimization of different diluents and different disintegrating agents with different Concentrations.
• To perform the stability studies 
IMPLICATIONS
Matrix pellets of swellable polymers or waxes, retain their controlled release characteristics to a larger extent even on compression since the release of drug from such pellets depend upon swelling or erosion of matrix rather than by diffusion through the membrane. However, an important point that needs consideration in the design of MUPS of such matrix pellets is fusion of pellets with each other during compaction which may not be obvious during compression of coated pellets. Fusion of matrix pellets as a result of compaction can be avoided by application of film coating on such pellets or excessive blending with a hydrophobic agent separately prior to mixing them other extra granular materials before
